Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

RECURSION PHARMACEUTICALS, INC.

(RXRX)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
09/13/2021 09/14/2021 09/15/2021 09/16/2021 09/17/2021 Date
26.09(c) 25.77(c) 23.95(c) 24.26(c) 26.81 Last
616 072 539 133 743 533 1 430 329 3 063 665 Volume
-7.78% -1.23% -7.06% +1.29% +10.51% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 10,3 M - -
Net income 2021 -165 M - -
Net cash position 2021 537 M - -
P/E ratio 2021 -19,9x
Yield 2021 -
Sales 2022 11,0 M - -
Net income 2022 -218 M - -
Net cash position 2022 326 M - -
P/E ratio 2022 -20,2x
Yield 2022 -
Capitalization 4 517 M 4 517 M -
EV / Sales 2021 385x
EV / Sales 2022 380x
Nbr of Employees 270
Free-Float 77,6%
More Financials
Company
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company. The Company uses Recursion Operating System (Recursion OS), a multi-layer system for generating, analyzing and deriving insights from biological and chemical datasets. It consists of three parts: Infrastructure Layer, The Recursion Data Universe and The Recursion Map. Its programs include REC-4881, REC-3599, REC-2282, REC-994, lead molecules... 
More about the company
All news about RECURSION PHARMACEUTICALS, INC.
09/09RECURSION PHARMACEUTICALS, INC. : Regulation FD Disclosure, Financial Statements..
AQ
08/16RECURSION PHARMACEUTICALS : SVB Leerink Adjusts Recursion Pharmaceuticals' Price..
MT
08/13RECURSION PHARMACEUTICALS : Q2 Earnings Snapshot
AQ
08/13RECURSION PHARMACEUTICALS : Management's Discussion and Analysis of Financial Co..
AQ
08/13RECURSION PHARMACEUTICALS : Reports Second Quarter 2021 Financials and Provides ..
PU
08/13RECURSION PHARMACEUTICALS, INC. : Results of Operations and Financial Condition,..
AQ
08/13RECURSION : Reports Second Quarter 2021 Financials and Provides Business Updates
PR
08/13RECURSION PHARMACEUTICALS : Earnings Flash (RXRX) RECURSION Posts Q2 Revenue $2...
MT
08/13Recursion Pharmaceuticals, Inc. Announces Unaudited Consolidated Earnings Res..
CI
07/13RECURSION PHARMACEUTICALS : Announces Therapeutics Advisory Board, Chaired by Jo..
PU
07/13RECURSION PHARMACEUTICALS, INC. : Regulation FD Disclosure, Financial Statements..
AQ
07/13RECURSION : Announces Therapeutics Advisory Board, Chaired by Joseph Miletich, M..
PR
07/13Recursion Announces Therapeutics Advisory Board, Chaired by Joseph Miletich
CI
07/12RECURSION : Opens Child Care Center to Support Employees
PR
07/01RECURSION PHARMACEUTICALS : Expands Salt Lake City Headquarters
MT
More news
News in other languages on RECURSION PHARMACEUTICALS, INC.

- No features available -

More news
Analyst Recommendations on RECURSION PHARMACEUTICALS, INC.
More recommendations
Chart RECURSION PHARMACEUTICALS, INC.
Duration : Period :
Recursion Pharmaceuticals, Inc. Technical Analysis Chart | RXRX | US75629V1044 | MarketScreener
Technical analysis trends RECURSION PHARMACEUTICALS, INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Last Close Price 26,81 $
Average target price 32,40 $
Spread / Average Target 20,9%
EPS Revisions
Managers and Directors
Chistopher C. Gibson Chief Executive Officer & Director
Tina Larson President & Chief Operating Officer
Michael Secora Chief Financial Officer
Ramon Martin Chavez Márquez Independent Chairman
Benjamin Mabey Chief Technology Officer
Sector and Competitors
1st jan.Capi. (M$)
RECURSION PHARMACEUTICALS, INC.0.00%4 087
BIONTECH SE357.13%90 003
GILEAD SCIENCES, INC.22.43%89 434
REGENERON PHARMACEUTICALS35.20%67 910
WUXI APPTEC CO., LTD.35.75%65 728
VERTEX PHARMACEUTICALS-20.83%48 539